Rodney W Lappe insider trades: Design Therapeutics (DSGN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rodney reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | DSGN | ↑ Buy | 21,000 | $2.35 | $49K | Direct | Oct 2, 2023 (3d) |
| Dec 9, 2022 | DSGN | ↑ Buy | 15,000 | $7.96 | $119K | Direct | Dec 12, 2022 (3d) |
| Mar 30, 2021 | DSGN | ↑ Buy | 5,000 | $20.00 | $100K | Direct | Apr 1, 2021 (2d) |
| Jan 6, 2017 | MRTX | ↑ Buy | 286,163 | $5.60 | $1.6M | Direct | Jan 10, 2017 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Rodney W Lappe's insider trades
Rodney W Lappe is an insider at Design Therapeutics (DSGN). Since Jan 6, 2017, Rodney has reported 4 open-market purchases worth $1.9M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DSGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.